Makes sense, but MNKD mgmt should have been a bit more transparent. how are you able to determine the location where the concentration of the prescription is occurring?
Yes they do hence termination. All contractural obmigations are terminated once you no longer work for a company. Ita not like Hakan has top secerets or CIA intel.
I doubt he has a contract unless the contract was furnished when his title was removed. I think its more b/c of the NDA (non disclosure agreement) he signed. They probably dont want him spilling the beans or they want to keep him until whatever terms or future arrangements was made with SNY or any other BP. Look if they wanted him out for good it would have been done. I also beleive an external entity, big money investor, wants him out of the CEO role.
EU approved Exubera 3 months after it was approved. I beleive that SNY will buyout MNKD by end of year or Q1 2016. No doubt about it.
Whose selling Afrezza?
Make sure you cover and not end yp owing 106k
What are you smoking. Too much stuffing. SNY better start ramling up sales or MNKD is going to pull the plug. Al has mysterous friends that can shake this up. It is obvious that SNY needs MNKD more than MNKD needs them. SNY share has dropped significantly from last Q3 call and their insulin pipeline is not doing well. Afrezza is their savior.
Steve Job has nothing compared to Al Mann. Steve probably has created more deaths and Al has saved lives.